STARGARDT DISEASE

Clinical trials for STARGARDT DISEASE explained in plain language.

Never miss a new study

Get alerted when new STARGARDT DISEASE trials appear

Sign up with your email to follow new studies for STARGARDT DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 3 Not yet finished but already full! 1

Gene therapy shows promise in slowing stargardt disease blindness

Disease control Ongoing

This study tests a gene therapy called OCU410ST for people with Stargardt disease, an inherited eye condition that causes vision loss. Early results show the treatment slowed retinal damage by 48% and improved vision in some patients. The current phase will enroll 51 people aged …

Matched conditions: STARGARDT DISEASE

Phase: PHASE2, PHASE3 • Sponsor: Ocugen • Aim: Disease control

Last updated May 17, 2026 05:33 UTC

STARGARDT DISEASE

Get alerted when new STARGARDT DISEASE trials appear

Gene therapy shows promise in slowing stargardt disease blindness